Effects Toxics Clinical Trial
Official title:
The Effect and Frequency of Helicobacter Pylori Infection in Primary Immune Thrombocytopenic Patients Not Respond on Steroid Therapy.
| Verified date | May 2017 |
| Source | Assiut University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet count
(i.e less than 100.000) . In ITP, platelet surface membrane proteins become antigenic for
unknown reasons , leading to stimulation of the immune system , autoantibody production, and
platelet destruction In recent years ,the list of etiologies of ITP has been steadily
increasing, so the term "idiopathic" is becoming obsolete, increasingly replaced by
"immune"TP .
Treatment of ITP may be conceptually divided into rescue therapy and maintenance therapy .
the terminology of corticosteroid-dependence means The need for ongoing or repeated doses
administration of corticosteroids for at least 2 months to maintain a platelet count at or
above 30 _ 109/L and/or to avoid bleeding. So, patients with corticosteroid dependence are
considered non responders
| Status | Not yet recruiting |
| Enrollment | 100 |
| Est. completion date | June 1, 2018 |
| Est. primary completion date | June 1, 2018 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: 1.Patients diagnosed ITP and failed on steroid therapy. Exclusion Criteria: 1. Patients with systemic lupus erythromatous 2. Drug administration 3. Hepatitis c infection |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Assiut University |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Percentage of primary thrombocytopenic patients with helicobacter pylori infection who recieved its treatment and improved clinically and laboratory. | one year |